BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Australia's First Cu-67 SAR-Bombesin Prostate Cancer Trial Patient Treated

COMBAT, which derives from "Copper-67 SAR-Bombesin in metastatic castrate resistant prostate cancer (NCT05633160)1 is a dose escalation and co...

October 04, 2023 | News

FDA Clears Transcenta for Global Phase III Trial of Osemitamab in Gastric Cancer

Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, resear...

October 04, 2023 | News

Akeso and RemeGen Team Up for Gastric Cancer Therapy Study

On September 28, 2023, Akeso (9926.HK) announced that its subsidiary, Akeso Pharma, will collaborate with RemeGen (Yantai) Co., Ltd. (688331.SH/0...

October 02, 2023 | News

Mabwell Starts Phase Ib/II Trial for Nectin-4 ADC with PD-1 Inhibitor

The clinical trial (CTR20232677) is to evaluate the safety, tolerability, preliminary efficacy, and pharmacokinetic profile of 9MW2821 in combination with ...

September 29, 2023 | News

Advanced Cancer Imaging Tool Streamlines Radiotherapy Adjustment for Doctors

An innovative technology that captures high-quality images of a tumor in six seconds is being used to guide cancer treatments for patients receiving care a...

September 29, 2023 | News

BioCity and AstraZeneca Collaborate on Hepatocellular Carcinoma Treatment in China

BioCity will lead the trial, which has received IND approval by the National Medical Products Administration (NMPA). The study will be conducted at Zhongsh...

September 28, 2023 | News

Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients

Many lung cancer patients are grappling with a multitude of symptoms throughout their treatment process, including but not limited to fatigue, reduced appe...

September 26, 2023 | News

AstraZeneca and Institut Kanser Negara Collaborate to Introduce AI Lung Screening in Malaysia

In conjunction with Institut Kanser Negara's (IKN) 10th anniversary, AstraZeneca announced its collaboration to accelerate digitalisati...

September 25, 2023 | News

Asieris Pharmaceuticals' APL-1702 Achieves Key Milestone in Cervical HSIL Treatment Trial

Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs fo...

September 21, 2023 | News

Samsung Biologics Expands Agreement with Bristol Myers Squibb to Manufacture Cancer Drug

Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the s...

September 18, 2023 | News

Singleron Unveils AccuraCode® TCR Kit for Streamlined T-Cell Profiling

The product is built upon Singleron's molecular barcoding technology, enabling multiplexing of 96 or 384 samples in a single library construction reaction....

September 14, 2023 | News

Lunit Study Backs AI as Effective Alternative to Single Human Reader in European Double Reading System

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, is spearheading a transformative change in...

September 12, 2023 | News

Sirtex partners with Magle Group to advance the international treatment of liver and lung cancer

Sirtex Medical ("Sirtex"), a leading manufacturer of interventional treatment solutions, announced the establishment of a collaboration and exclusive...

September 11, 2023 | News

Genmab and Seagen Report TIVDAK® Success in Cervical Cancer Survival Trial

Phase 3 innovaTV 301 confirmatory trial met its primary endpoint of improved overall survival (OS) at predetermined, independent interim analysis ...

September 05, 2023 | News

Stay Connected